Dr. Danciu on Prescreening and Identifying Breast Cancer Survivors

Video

Oana C. Danciu, MD, assistant professor of Medicine, Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, discusses a study examining a team-based approach to prescreen and identify breast cancer survivors using a survivorship care plan.

Oana C. Danciu, MD, assistant professor of Medicine, Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, discusses a study examining a team-based approach to prescreen and identify breast cancer survivors using a survivorship care plan.

Previously, the multidisciplinary approach of a survivorship care plan was reaching 25% of patients at the University of Illinois, Danciu explains. However, the goal was to reach 100%. Therefore, the team prescreened patients and identified those who qualified as survivors; survivors were defined as patients who completed their active treatments.

The clinic was able to reach above 90% compliance with the new team-based approach. Most recently, the University of Illinois has established a breast cancer survivorship clinic, where oncologists discuss survivorship issues and review care plans and treatment summaries. Danciu predicts this will help the clinic reach 100% compliance.

Related Videos
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Erin K. Crane, MD, MPH
Omid Hamid, MD
Eric Vallieres, MD, FRCSC
Josep Maria Piulats Rodriguez, MD, PhD
Samer A. Srour, MB ChB, MS
William B. Pearse, MD
Núria Agustí Garcia, MD
Mikkael A. Sekeres, MD, MS